US6471992B1
(en)
|
1997-02-20 |
2002-10-29 |
Therics, Inc. |
Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
|
CN1195500C
(zh)
*
|
1998-05-18 |
2005-04-06 |
武田药品工业株式会社 |
可口腔崩解的片剂
|
US6284270B1
(en)
*
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
EP1301177A2
(en)
*
|
2000-07-10 |
2003-04-16 |
Therics, Inc. |
Method and materials for controlling migration of binder liquid in a powder
|
US7014867B2
(en)
*
|
2001-06-28 |
2006-03-21 |
Ucb Farchim Sa |
Tablet comprising cetirizine and pseudoephedrine
|
KR100892333B1
(ko)
*
|
2001-07-10 |
2009-04-08 |
테바 파마슈티컬 인더스트리즈 리미티드 |
0차, 0차-2상, 증가적 또는 감소적 약물 전달을 위한 약물전달 시스템
|
JP4845340B2
(ja)
*
|
2001-10-29 |
2011-12-28 |
マサチューセッツ インスティテュート オブ テクノロジー |
三次元プリント投薬形態のような物品の一軸圧縮のためのシステムおよび方法
|
US20030099708A1
(en)
*
|
2001-10-29 |
2003-05-29 |
Therics, Inc |
Printing or dispensing a suspension such as three-dimensional printing of dosage forms
|
AU2003232078A1
(en)
|
2002-05-06 |
2003-11-17 |
Massachusetts Institute Of Technology |
Diffusion-controlled dosage form and method of fabrication including three dimensional printing
|
WO2004047793A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Alk-Abelló A/S |
Pharmaceutical allergen product
|
DK1804804T3
(da)
|
2004-09-21 |
2012-02-20 |
Hypnion Inc |
3-[4-(dibenzo[b,f][1,4]oxazepin-11-yl)-piperazin-1-yl]-2,2-dimethylpropansyre til anvendelse ved behandlingen af søvnforstyrrelser
|
US7829000B2
(en)
*
|
2005-02-25 |
2010-11-09 |
Hewlett-Packard Development Company, L.P. |
Core-shell solid freeform fabrication
|
US8187659B2
(en)
|
2006-05-02 |
2012-05-29 |
Jerry Robertson Real Estate Llc |
Solid medicament dosage form consumption aid
|
ES2500165T3
(es)
|
2006-06-29 |
2014-09-30 |
Kinex Pharmaceuticals, Llc |
Composiciones de biarilo y métodos para modular una cascada de quinasas
|
WO2009051848A1
(en)
|
2007-10-20 |
2009-04-23 |
Kinex Pharmaceuticals, Llc |
Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
|
MY150626A
(en)
|
2009-10-30 |
2014-02-07 |
Ix Biopharma Ltd |
Fast dissolving solid dosage form
|
ES2634551T3
(es)
*
|
2010-04-03 |
2017-09-28 |
Praful Doshi |
Métodos para revestir una lente de contacto
|
EP2632920A1
(en)
|
2010-10-27 |
2013-09-04 |
Dynamix Pharmaceuticals Ltd. |
Sulfonamides for the modulation of pkm2
|
WO2012088438A1
(en)
|
2010-12-22 |
2012-06-28 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
WO2012106058A2
(en)
|
2011-01-31 |
2012-08-09 |
New Market Pharmaceuticals |
Animal treatments
|
WO2012122370A2
(en)
|
2011-03-08 |
2012-09-13 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
ITMI20110792A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
|
ITMI20110791A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri in grado di metabolizzare gli ossalati.
|
ITMI20110793A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
|
WO2012160447A1
(en)
|
2011-05-25 |
2012-11-29 |
Dynamix Pharmaceuticals Ltd. |
3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
|
PL2718290T3
(pl)
|
2011-06-07 |
2016-11-30 |
|
Kompozycje i sposoby modulowania kinazy
|
ITMI20111718A1
(it)
|
2011-09-23 |
2013-03-24 |
Probiotical Spa |
Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
|
US9245061B2
(en)
*
|
2012-04-25 |
2016-01-26 |
Shapeways, Inc. |
Weight-based identification of three dimensional printed parts
|
BR112014027352B1
(pt)
|
2012-05-02 |
2022-10-25 |
New Market Pharmaceuticals |
Composições farmacêuticas para a introdução sistêmica direta
|
US20150150869A1
(en)
|
2012-06-20 |
2015-06-04 |
Eutropics Pharmaceuticals, Inc. |
Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
|
SI2890680T1
(en)
|
2012-08-30 |
2018-08-31 |
Athenex, Inc. Conventus Building |
N- (3-FLUOROBENZYL) -2- (5- (4-MORFOLINOPHENYL) PIRIDIN-2-IL) ACETAMIDE AS PROTEIN TIROZINE KINASE PROTECTORS
|
US9545376B2
(en)
|
2013-01-23 |
2017-01-17 |
Arx, Llc |
Production of unit dose constructs
|
CA2906107C
(en)
*
|
2013-03-15 |
2021-08-24 |
Aprecia Pharmaceuticals Company |
Rapidly dispersible dosage form of oxcarbazepine
|
CN105050588B
(zh)
*
|
2013-03-15 |
2019-01-15 |
阿普雷奇亚制药有限责任公司 |
托吡酯的快速分散剂型
|
US9339489B2
(en)
|
2013-03-15 |
2016-05-17 |
Aprecia Pharmaceuticals Company |
Rapid disperse dosage form containing levetiracetam
|
CN105188849B
(zh)
*
|
2013-03-15 |
2019-01-15 |
阿普雷奇亚制药有限责任公司 |
包含左乙拉西坦的快速分散剂型
|
WO2014176389A1
(en)
|
2013-04-24 |
2014-10-30 |
Temple University - Of The Commonwealth System Of Higher Education |
Solid dosage form containing arabinogalactan
|
ITMI20130793A1
(it)
|
2013-05-14 |
2014-11-15 |
Probiotical Spa |
Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
|
KR102171123B1
(ko)
|
2013-08-16 |
2020-10-29 |
더 엑스원 컴퍼니 |
3차원 인쇄된 금속 주조용 몰드 및 그를 제조하기 위한 방법
|
JP2016540887A
(ja)
|
2013-10-17 |
2016-12-28 |
ザ エクスワン カンパニー |
3次元印刷された熱間静水圧加圧成形用容器及びその製造方法
|
EP3086922B1
(en)
|
2013-12-23 |
2022-03-09 |
The Exone Company |
Method of three-dimensional printing using a multi-component build powder
|
ES2744846T3
(es)
*
|
2013-12-23 |
2020-02-26 |
The Exone Co |
Métodos y sistemas para la impresión en tres dimensiones, utilizando un fluido aglutinante de partículas inyectadas
|
US20160332373A1
(en)
|
2013-12-23 |
2016-11-17 |
The Exone Company |
Methods and Systems for Three-Dimensional Printing Utilizing Multiple Binder Fluids
|
US20160184230A1
(en)
*
|
2014-04-30 |
2016-06-30 |
Aron H. Blaesi |
Melt-processed polymeric cellular dosage form
|
WO2015183796A1
(en)
|
2014-05-29 |
2015-12-03 |
The Exone Company |
Process for making nickel-based superalloy articles by three-dimensional printing
|
WO2016011098A2
(en)
|
2014-07-17 |
2016-01-21 |
The Exone Company |
Methods and apparatuses for curing three-dimensional printed articles
|
KR102580378B1
(ko)
|
2014-11-21 |
2023-09-19 |
바이오하벤 파마슈티컬 홀딩 컴퍼니 엘티디. |
릴루졸의 설하 제제
|
CN107206746A
(zh)
|
2014-12-03 |
2017-09-26 |
艾克斯温有限责任公司 |
通过三维打印制造致密碳制品的方法
|
US10363220B2
(en)
|
2015-06-03 |
2019-07-30 |
Triastek, Inc. |
Compartmented pharmaceutical dosage forms
|
EP3108874A1
(en)
*
|
2015-06-26 |
2016-12-28 |
TRB Chemedica AG |
Ophthalmologic pharmaceutical composition
|
US11129798B2
(en)
*
|
2016-08-19 |
2021-09-28 |
Aron H. Blaesi |
Fibrous dosage form
|
WO2017158172A1
(en)
*
|
2016-03-18 |
2017-09-21 |
Grünenthal GmbH |
Combination of drugs having different potency
|
WO2017175792A1
(ja)
*
|
2016-04-06 |
2017-10-12 |
アステラス製薬株式会社 |
速溶出性三次元造形物、速溶出性三次元造形物用フィラメント及び速溶出性三次元造形物用材料
|
JP6559912B2
(ja)
|
2016-05-05 |
2019-08-14 |
トリアステック インコーポレイテッド |
放出制御剤形
|
ES2912131T3
(es)
|
2016-05-20 |
2022-05-24 |
Biohaven Therapeutics Ltd |
Uso de agentes moduladores del glutamato con inmunoterapias para tratar el cáncer
|
CA3032586A1
(en)
|
2016-08-12 |
2018-02-15 |
Athenex, Inc. |
Biaryl compounds and use thereof for modulating a kinase cascade
|
EP3529023B1
(en)
|
2016-10-19 |
2022-05-25 |
Shapeways, Inc. |
Systems and methods for identifying three-dimensional printed objects
|
MX2019007923A
(es)
|
2016-12-31 |
2019-09-10 |
Bioxcel Therapeutics Inc |
Uso de dexmedetomidina sublingual para el tratamiento de la agitacion.
|
US11602502B2
(en)
|
2017-02-24 |
2023-03-14 |
Hewlett-Packard Development Company, L.P. |
Three-dimensional (3D) printing a pharmaceutical tablet
|
CA3053254C
(en)
|
2017-03-08 |
2024-02-20 |
Cinrx Pharma, Llc |
Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
|
KR102626745B1
(ko)
|
2017-05-26 |
2024-01-17 |
인피니트 머티리얼 솔루션즈, 엘엘씨 |
수용성 중합체 조성물
|
WO2019094851A1
(en)
|
2017-11-12 |
2019-05-16 |
Biohaven Pharmaceutical Holding Company Ltd. |
Use of riluzole prodrugs to treat ataxias
|
CN108066302B
(zh)
*
|
2017-12-28 |
2020-09-11 |
无限极(中国)有限公司 |
一种快速分散固体制剂的制备方法及制备的快速分散固体制剂
|
US10350822B1
(en)
|
2018-01-09 |
2019-07-16 |
Triastek Inc. |
Dosage forms with desired release profiles and methods of designing and making thereof
|
CN116270513A
(zh)
|
2018-01-09 |
2023-06-23 |
南京三迭纪医药科技有限公司 |
一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
|
DE102018107585B3
(de)
*
|
2018-03-29 |
2019-03-28 |
Universität Rostock |
Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen
|
US10792246B2
(en)
|
2018-06-27 |
2020-10-06 |
Bioxcel Therapeutics, Inc. |
Film formulations containing dexmedetomidine and methods of producing them
|
SG11202103708RA
(en)
|
2018-10-15 |
2021-05-28 |
Aprecia Pharmaceuticals LLC |
Method and system for forming a dosage form within a packaging
|
US20220016074A1
(en)
|
2018-11-21 |
2022-01-20 |
Rosemont Pharmaceuticals Limited |
Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
|
JP7287032B2
(ja)
|
2019-03-20 |
2023-06-06 |
株式会社リコー |
シート、シート積層体、医薬品、シートの製造方法、及びシート積層体の製造方法
|
WO2020234335A1
(en)
*
|
2019-05-21 |
2020-11-26 |
Dfe Pharma Gmbh & Co. Kg |
Lactose powder bed three dimensional printing
|
US20240024288A1
(en)
|
2019-07-19 |
2024-01-25 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
TWI734309B
(zh)
*
|
2019-12-19 |
2021-07-21 |
水星生醫股份有限公司 |
滲透性噴塗製作藥錠裝置
|
WO2021263132A1
(en)
|
2020-06-26 |
2021-12-30 |
Aprecia Pharmaceuticals LLC |
Rapidly-orodispersible tablets having an interior cavity
|
WO2022089588A1
(zh)
|
2020-10-30 |
2022-05-05 |
南京三迭纪医药科技有限公司 |
胃滞留药物剂型
|
WO2024108082A1
(en)
|
2022-11-18 |
2024-05-23 |
Aprecia Pharmaceuticals LLC |
Orodispersive dosage forms containing droxidopa
|